10% have a good outcome in that the pain has gone, but the movement may become restricted again after surgery
These symptoms may indicate a serious interaction or underlying condition requiring medical attention
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease
Changes in the menstrual cycle are not listed as a side effect in the official prescribing information for Zepbound
Results vary based on individual factors, treatment duration, and overall metabolic health.
Patients with certain GLP1R variants may metabolize semaglutide more efficiently, reducing cramping risk, while others experience amplified side effects at standard doses